Ariel E. Marciscano

3.4k total citations · 1 hit paper
53 papers, 2.1k citations indexed

About

Ariel E. Marciscano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ariel E. Marciscano has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Immunology. Recurrent topics in Ariel E. Marciscano's work include Cancer Immunotherapy and Biomarkers (14 papers), Advanced Radiotherapy Techniques (9 papers) and Immunotherapy and Immune Responses (9 papers). Ariel E. Marciscano is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Advanced Radiotherapy Techniques (9 papers) and Immunotherapy and Immune Responses (9 papers). Ariel E. Marciscano collaborates with scholars based in United States, Canada and United Kingdom. Ariel E. Marciscano's co-authors include Charles G. Drake, Dario A.A. Vignali, Lawrence P. Andrews, Niroshana Anandasabapathy, Matthew E. Hardee, Mary Helen Barcellos‐Hoff, Ashwatha Narayana, Scott Lonning, David Zagzag and Silvia C. Formenti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ariel E. Marciscano

46 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LAG3 (CD223) as a cancer immunotherapy target

2017 684 citations Ariel E. Marciscano, Charles G. Drake et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariel E. Marciscano United States	16	1.3k	817	562	371	287	53	2.1k
Emma C. Scott United States	10	2.3k 1.8×	1.3k 1.6×	346 0.6×	661 1.8×	357 1.2×	27	3.2k
Monica Loghin United States	14	1.7k 1.4×	452 0.6×	703 1.3×	493 1.3×	180 0.6×	45	2.7k
Heather H. Sun United States	14	1.6k 1.2×	760 0.9×	335 0.6×	712 1.9×	177 0.6×	19	2.6k
Deepika Cattry United States	3	2.2k 1.7×	1.2k 1.5×	333 0.6×	285 0.8×	101 0.4×	4	2.7k
Dan S. Gombos United States	22	624 0.5×	334 0.4×	414 0.7×	457 1.2×	183 0.6×	87	1.9k
Martin Erlanson Sweden	25	1.2k 0.9×	543 0.7×	364 0.6×	415 1.1×	67 0.2×	67	2.3k
Scott Ely United States	28	1.6k 1.3×	674 0.8×	331 0.6×	1.3k 3.5×	309 1.1×	89	3.4k
Carol O’Hear United States	25	2.1k 1.6×	718 0.9×	680 1.2×	378 1.0×	76 0.3×	58	2.4k
Lauren Pinter‐Brown United States	26	1.3k 1.1×	1.2k 1.4×	132 0.2×	710 1.9×	322 1.1×	99	3.3k
Carmen Timke Germany	23	1.1k 0.9×	623 0.8×	706 1.3×	485 1.3×	121 0.4×	49	2.2k

Countries citing papers authored by Ariel E. Marciscano

Since Specialization

Citations

This map shows the geographic impact of Ariel E. Marciscano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel E. Marciscano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel E. Marciscano more than expected).

Fields of papers citing papers by Ariel E. Marciscano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel E. Marciscano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel E. Marciscano. The network helps show where Ariel E. Marciscano may publish in the future.

Co-authorship network of co-authors of Ariel E. Marciscano

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel E. Marciscano. A scholar is included among the top collaborators of Ariel E. Marciscano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel E. Marciscano. Ariel E. Marciscano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marciscano, Ariel E., et al.. (2025). Extent of resection and adjuvant treatment in adult cerebellar glioblastoma: systematic review and meta-analysis of survival outcomes. Journal of Neuro-Oncology. 176(2). 138–138.

Jackson, Will, Robert T. Dess, Angela Y. Jia, et al.. (2025). Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results.. Journal of Clinical Oncology. 43(5_suppl). 387–387.

Villa-Pulgarín, Janny A., Francesca Khani, Jian Wu, et al.. (2024). Radiation-Induced TREM2-Expression on Tumor-Associated Macrophages Is a Target for Modulation of Immune Responses in Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S98–S98.

Ballman, Karla V., Ariel E. Marciscano, Christopher E. Barbieri, et al.. (2024). Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE). BMC Urology. 24(1). 151–151. 2 indexed citations

Nagar, Himanshu, Xi Kathy Zhou, Christopher E. Barbieri, et al.. (2024). 1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks. Radiotherapy and Oncology. 194. S2478–S2479.

Wisdom, Amy J., Christopher A. Barker, Joe Y. Chang, et al.. (2024). The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1404–1421. 15 indexed citations

Marciscano, Ariel E., Xi Kathy Zhou, Christopher E. Barbieri, et al.. (2023). Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). BMC Cancer. 23(1). 781–781. 6 indexed citations

Marciscano, Ariel E., et al.. (2023). Image-guided radiation therapy of tumors in preclinical models. Methods in cell biology. 180. 1–13.

Ma, Xiaoyue, et al.. (2023). Differential Use of Radiotherapy Fractionation Regimens in Prostate Cancer. JAMA Network Open. 6(10). e2337165–e2337165. 6 indexed citations

10.

Marciscano, Ariel E., Xi Kathy Zhou, Amar U. Kishan, et al.. (2023). A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT). BMC Cancer. 23(1). 923–923. 10 indexed citations

11.

Imber, Brandon S., Debra A. Goldman, Zhigang Zhang, et al.. (2020). Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer. Advances in Radiation Oncology. 5(6). 1213–1224. 11 indexed citations

12.

Marciscano, Ariel E., Adriana Haimovitz‐Friedman, Percy Lee, et al.. (2019). Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities. International Journal of Radiation Oncology*Biology*Physics. 110(1). 35–52. 58 indexed citations

13.

Francica, Brian J., Ali Ghasemzadeh, Anthony L. Desbien, et al.. (2018). TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors. Cancer Immunology Research. 6(4). 422–433. 67 indexed citations

14.

Marciscano, Ariel E., Joshua M. Walker, Heather M. McGee, et al.. (2018). Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. Journal for ImmunoTherapy of Cancer. 6(1). 6–6. 22 indexed citations

15.

Peng, Luke, Amol Narang, Noura Radwan, et al.. (2018). Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urologic Oncology Seminars and Original Investigations. 36(6). 309.e7–309.e14. 9 indexed citations

16.

Marciscano, Ariel E. & Ravi A. Madan. (2018). Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies. Current Treatment Options in Oncology. 19(3). 16–16. 6 indexed citations

17.

Muroyama, Yuki, Thomas R. Nirschl, Christina M. Kochel, et al.. (2017). Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer Immunology Research. 5(11). 992–1004. 166 indexed citations

18.

Hwang, William L., Ariel E. Marciscano, Anat Stemmer‐Rachamimov, et al.. (2015). Correlation of Imaging Characteristics With Histopathological WHO Grade in Meningiomas. International Journal of Radiation Oncology*Biology*Physics. 93(3). E86–E86.

19.

Pellicciotta, Ilenia, Ariel E. Marciscano, Matthew E. Hardee, et al.. (2015). Development of a novel multiplexed assay for quantification of transforming growth factor-β(TGF-β). Growth Factors. 33(2). 79–91. 8 indexed citations

20.

Sethi, Rajni, et al.. (2013). Is there a role for an external beam boost in cervical cancer radiotherapy?†. Frontiers in Oncology. 3. 3–3. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact